Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 295-297

  Chacon Moreno, Brenda Edith ^a   Welsh, Oliverio ^a   Cavazos Rocha, Norma ^b   Salazar Cavazos, Maria De La Luz ^b   Garza Lozano, Hector Gerardo ^c   Said Fernandez, Salvador ^c   Ocampo Candiani, Jorge ^a   Vera Cabrera, Lucio ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; MOXIFLOXACIN;

ACTINOMYCETOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; IN VITRO STUDY; MONOTHERAPY; MOUSE; MULTIPLE CYCLE TREATMENT; NOCARDIA BRASILIENSIS; NOCARDIOSIS; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; AZA COMPOUNDS; CIPROFLOXACIN; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MYCETOMA; NOCARDIA; QUINOLINES;

EID: 59749097995     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01023-08     Document Type: Article

References (12)

1. Alangaden, G. J., and S. A. Lerner. 1997. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. Clin. Infect. Dis. 25:1213-1221.
2. Bath, P. M., K. W. Pettingale, and J. Wade. 1989. Treatment of multiple subcutaneous Nocardia asteroides abscesses with ciprofloxacin and doxycycline. Postgrad. Med. J. 65:190-191.
3. Daw-Garza, A., O. Welsh, S. Said-Fernández, H. G. Lozano-Garza, N. Waksman de Torres, N. C. Rocha, J. Ocampo-Candiani, and L. Vera-Cabrera. 2008. In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis. Antimicrob. Agents Chemother. 52:1549-1550.
4. Espinoza-González, N. A., O. Welsh, N. W. de Torres, N. Cavazos-Rocha, J. Ocampo-Candiani, S. Said-Fernandez, G. Lozano-Garza, S. H. Choi, and L. Vera-Cabrera. 2008. Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis. Molecules 13:31-40.
5. Foster, P. L. 2006. Methods for determining spontaneous mutation rates. Methods Enzymol. 409:195-213.
6. Peloquin, C. A., D. J. Hadad, L. P. Molino, M. Palaci, W. H. Boom, R. Dietze, and J. L. Johnson. 2008. Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis. Antimicrob. Agents Chemother. 52:852-857.
7. Rosche, W. A., and P. L. Foster. 2000. Determining mutation rates in bacterial populations. Methods 20:4-17.
8. Tripodi, M. F., L. E. Adinolfi, A. Andreana, G. Sarnataro, E. Durante Mangoni, M. Gambardella, R. Casillo, C. Farina, and R. Utili. 2001. Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies. Clin. Transplant. 15:415-420.
9. Vera-Cabrera, L., E. Gonzalez, S. H. Choi, and O. Welsh. 2004. In vitro activities of new antimicrobials against Nocardia brasiliensis. Antimicrob. Agents Chemother. 48:602-604.
10. Welsh, O., L. Vera-Cabrera, and M. C. Salinas-Carmona. 2007. Mycetoma. Clin. Dermatol. 25:195-202.
11. Yadav, V., and K. Deopujari. 2006. Gatifloxacin and dysglycemia in older adults. N. Engl. J. Med. 354:2725-2726.
12. Yew, W. W., P. C. Wong, S. Y. Kwan, C. Y. Chan, and M. S. Li. 1991. Two cases of Nocardia asteroides sternotomy infection treated with ofloxacin and a review of other active antimicrobial agents. J. Infect. 23:297-302.